PL364907A1 - Bis-heterocykliczne związki posiadające aktywnośćprzeciwrakową i uwrażliwiającą na chemioterapię - Google Patents

Bis-heterocykliczne związki posiadające aktywnośćprzeciwrakową i uwrażliwiającą na chemioterapię

Info

Publication number
PL364907A1
PL364907A1 PL01364907A PL36490701A PL364907A1 PL 364907 A1 PL364907 A1 PL 364907A1 PL 01364907 A PL01364907 A PL 01364907A PL 36490701 A PL36490701 A PL 36490701A PL 364907 A1 PL364907 A1 PL 364907A1
Authority
PL
Poland
Prior art keywords
antitumour
bis
heterocyclic compounds
chemosensitising
activity
Prior art date
Application number
PL01364907A
Other languages
English (en)
Inventor
Mauro Marzi
Patrizia Minetti
Gian Piero Moretti
Giuseppe Giannini
Enrico Garattini
Sergio Penco
Maria Ornelia Tinti
Claudio Pisano
Original Assignee
Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.
Publication of PL364907A1 publication Critical patent/PL364907A1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/10—Indoles; Hydrogenated indoles with substituted hydrocarbon radicals attached to carbon atoms of the hetero ring
    • C07D209/12—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/20—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D233/22—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
PL01364907A 2000-11-03 2001-07-26 Bis-heterocykliczne związki posiadające aktywnośćprzeciwrakową i uwrażliwiającą na chemioterapię PL364907A1 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT2000RM000569A IT1317925B1 (it) 2000-11-03 2000-11-03 Bis-eterocicli ad attivita' antitumorale e chemosensibilizzante.
PCT/IT2001/000407 WO2002036561A1 (en) 2000-11-03 2001-07-26 Bis-heterocyclic compounds with antitumour and chemosensitising activity

Publications (1)

Publication Number Publication Date
PL364907A1 true PL364907A1 (pl) 2004-12-27

Family

ID=11454975

Family Applications (1)

Application Number Title Priority Date Filing Date
PL01364907A PL364907A1 (pl) 2000-11-03 2001-07-26 Bis-heterocykliczne związki posiadające aktywnośćprzeciwrakową i uwrażliwiającą na chemioterapię

Country Status (15)

Country Link
US (1) US7084166B2 (pl)
EP (1) EP1337511A1 (pl)
JP (1) JP2004513110A (pl)
KR (1) KR20030045165A (pl)
CN (2) CN1232518C (pl)
AU (2) AU2001284392B8 (pl)
BR (1) BR0115139A (pl)
CA (1) CA2427565A1 (pl)
CZ (1) CZ20031178A3 (pl)
HU (1) HUP0400584A2 (pl)
IT (1) IT1317925B1 (pl)
MX (1) MXPA03003942A (pl)
PL (1) PL364907A1 (pl)
SK (1) SK5352003A3 (pl)
WO (1) WO2002036561A1 (pl)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20060211759A1 (en) * 2001-07-26 2006-09-21 Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. Bis-heterocyclic compounds with antitumour and chemosensitising activity
US7528165B2 (en) 2001-12-13 2009-05-05 National Health Research Institutes Indole compounds
US7632955B2 (en) 2001-12-13 2009-12-15 National Health Research Institutes Indole compounds
TWI317634B (en) 2001-12-13 2009-12-01 Nat Health Research Institutes Aroyl indoles compounds
US6800655B2 (en) * 2002-08-20 2004-10-05 Sri International Analogs of indole-3-carbinol metabolites as chemotherapeutic and chemopreventive agents
ATE504568T1 (de) * 2003-08-07 2011-04-15 Nat Health Research Institutes Indol-verbindungen als inhibitoren der tubulin- polymerisation zur behandlung von angiogenesisbezogenen erkrankungen
DE10359462A1 (de) * 2003-12-17 2005-07-28 Westfälische Wilhelms-Universität Münster Neuartige Platinkomplexverbindungen, Verfahren zu deren Herstellung sowie deren Verwendung für die Herstellung einer pharmazeutischen Zusammensetzung zur Behandlung von Krebserkrankungen
US7456289B2 (en) 2004-12-31 2008-11-25 National Health Research Institutes Anti-tumor compounds
CA2609980C (en) * 2005-05-27 2015-10-13 Queen's University At Kingston Treatment of protein folding disorders
TW200716545A (en) * 2005-06-10 2007-05-01 Sigma Tau Ind Farmaceuti Indole derivatives having anti-tumor activity
US9969686B2 (en) * 2014-08-05 2018-05-15 Wisconsin Alumni Research Foundation Synthesis of diindolylmethanes and indolo[3,2-b]carbazoles, compounds formed thereby, and pharmaceutical compositions containing them
JP2020530477A (ja) * 2017-08-10 2020-10-22 ザ テキサス エーアンドエム ユニヴァーシティ システム Ｎｒ４ａ１リガンド、医薬組成物、及び関連する使用方法
KR102866533B1 (ko) 2018-04-12 2025-09-30 베르시컬러 테크놀로지스 엘엘씨 말라세지아-유래 화합물 및/또는 이의 화학적 유사체를 함유하는 광보호 조성물
JP2021535123A (ja) 2018-08-24 2021-12-16 マイケル アインジガー， ｍａｌａｓｓｅｚｉａ由来の化合物および／またはその化学アナログを含有する光保護性組成物

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3738237A1 (de) * 1987-11-11 1989-05-24 Bayer Ag Bis-indolyl-ethylen
JPH09506335A (ja) 1993-09-22 1997-06-24 ザ、ウェルカム、ファンデーション、リミテッド 抗ウイルス剤としてのビス（アミノベンズイミダゾリル）アルカン
EP0887348A1 (en) * 1997-06-25 1998-12-30 Boehringer Mannheim Italia S.p.A. Bis-Indole derivatives having antimetastatic activity, a process for their preparation and pharmaceutical compositions containing them

Also Published As

Publication number Publication date
AU2007202805A1 (en) 2007-07-12
CN1232518C (zh) 2005-12-21
CN1473150A (zh) 2004-02-04
KR20030045165A (ko) 2003-06-09
EP1337511A1 (en) 2003-08-27
HK1061243A1 (en) 2004-09-10
HUP0400584A2 (hu) 2004-06-28
AU8439201A (en) 2002-05-15
CN100351234C (zh) 2007-11-28
AU2001284392B2 (en) 2007-03-08
CA2427565A1 (en) 2002-05-10
US20040053987A1 (en) 2004-03-18
IT1317925B1 (it) 2003-07-15
WO2002036561A1 (en) 2002-05-10
AU2001284392B8 (en) 2007-04-05
ITRM20000569A1 (it) 2002-05-03
ITRM20000569A0 (it) 2000-11-03
CN1733722A (zh) 2006-02-15
US7084166B2 (en) 2006-08-01
CZ20031178A3 (cs) 2003-11-12
SK5352003A3 (en) 2003-11-04
MXPA03003942A (es) 2004-05-24
JP2004513110A (ja) 2004-04-30
BR0115139A (pt) 2003-09-30

Similar Documents

Publication Publication Date Title
GB9926956D0 (en) Amplifier
GB9912350D0 (en) Modified cytokine
EP1237454A4 (en) PORTABLE SINK
AU141041S (en) Flashlight
GB9928355D0 (en) Amplifier
IL145995A0 (en) Use
AU8439201A (en) Bis-heterocyclic compounds with antitumour and chemosensitising activity
HUP0203896A3 (en) Substituted 8-arylquinoline phosphodiesterase-4-inhibitors and use thereof
GB9913536D0 (en) Use
AU141947S (en) Flashlight
GB9913548D0 (en) Amplifier
GB2353533B (en) Compounds and inks
TW407616U (en) Assembled and detachable carrier
EP1224886A4 (en) PORTABLE CASE
GB9924794D0 (en) Personal viewstation
GB9919971D0 (en) Use
AU4940801A (en) Antiprogestins with partial agonist activity
PL109418U1 (en) Portable derailer
GB2349346B (en) Disable multi-exercise
GB9912124D0 (en) Portable structure
PL333866A1 (en) Therapy-rehabilitation bed with antidecubital feature
GB9930174D0 (en) The portable internet-camcorder
GB9930612D0 (en) Street furniture
CA85508S (en) Backpack
TW392453U (en) Hammock device

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)